BIOCRYST PHARMACEUTICALS INC

Develops oral small-molecule drugs for rare diseases like hereditary angioedema.

BCRX | US

Overview

Corporate Details

ISIN(s):: US09058V1035
LEI:
Country:: United States of America
Address:: 4505 EMPEROR BOULEVARD, 27703 DURHAM
Website:: https://www.biocryst.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioCryst Pharmaceuticals Inc. is a commercial-stage biotechnology company focused on the discovery, development, and commercialization of novel medicines for rare diseases. The company specializes in creating oral small-molecule and protein therapeutics for patients with significant unmet medical needs, with a primary focus on hereditary angioedema (HAE) and other complement-mediated conditions. Founded in 1986, BioCryst utilizes a structure-guided drug design approach that combines biology, chemistry, and advanced technologies to develop first-in-class or best-in-class treatments. The company's mission is to improve patients' lives by advancing novel therapeutics globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIOCRYST PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOCRYST PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BIOCRYST PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

	Company	Country	Ticker
	Propanc Biopharma, Inc. Developing proenzyme therapies to prevent solid tumor recurrence and metastasis.	United States of America	PPCB
	ProQR Therapeutics N.V. Biotech developing RNA-editing therapies for genetic disorders using the body's own enzymes.	United States of America	PRQR
$Protagenic Therapeutics, Inc.\new Logo$	Protagenic Therapeutics, Inc.\new Developing novel peptide drugs to treat stress-related neuropsychiatric & CNS disorders.	United States of America	PTIX
	Protagonist Therapeutics, Inc Develops peptide therapeutics for blood disorders and inflammatory or immunomodulatory diseases.	United States of America	PTGX
	Protalix BioTherapeutics, Inc. Develops plant-cell-based protein therapies for rare diseases like Gaucher and Fabry.	United States of America	PLX
	Protara Therapeutics, Inc. Clinical-stage biotech developing cell therapies for cancer and rare diseases.	United States of America	TARA
	PROTEINA CO.,LTD. A biotech firm specializing in proteomics for drug discovery and diagnostics in oncology.	South Korea	468530
	PROTIA INC. Develops IVD kits and instruments for allergy, POCT, infectious & autoimmune diseases.	South Korea	303360
	Psych Capital Plc A life sciences firm developing psilocybin treatments for anorexia and mental health conditions.	United Kingdom	PSY
	PSYENCE BIOMEDICAL LTD. Developing natural psilocybin therapies for anxiety and depression in palliative care.	United States of America	PBM